Showing results (31-40 of 107) with videos related to

Sort By:
Pageof 11
British Journal of Haematology|July 22, 2014
SWOG0919: a Phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukaemiaAnjali S Advani, Shannon McDonough, Edward Copelan, et al.
British Journal of Haematology|March 4, 2014
SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemiaAnjali S Advani, Shannon McDonough, Steven Coutre, et al.
Leukemia Research|October 12, 2007
Increased C-kit intensity is a poor prognostic factor for progression-free and overall survival in patients with newly diagnosed AMLAnjali S Advani, Cristina Rodriguez, Tao Jin, et al.
Cancer|August 2, 2024
Inotuzumab ozogamicin in adult acute lymphoblastic leukemia: Development, current status, and future directionsHagop M Kantarjian, Nicolas Boissel, Cristina Papayannidis, et al.
Leukemia & Lymphoma|September 4, 2008
Time to post-remission therapy is an independent prognostic factor in adults with acute lymphoblastic leukemiaAnjali S Advani, Tao Jin, Giridharan Ramsingh, et al.
BMC Cancer|July 29, 2010
Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patientsAnjali S Advani, Sarah E Gibson, Elizabeth Douglas, et al.
European Journal of Haematology|June 26, 2012
Expression of phosphorylated signal transducer and activator of transcription 5 is associated with an increased risk of death in acute myeloid leukemiaAnna Brady, Sarah Gibson, Lisa Rybicki, et al.
Leukemia Research|February 7, 2018
Report of the relapsed/refractory cohort of SWOG S0919: A phase 2 study of idarubicin and cytarabine in combination with pravastatin for acute myelogenous leukemia (AML)Anjali S Advani, Hongli Li, Laura C Michaelis, et al.
British Journal of Haematology|March 8, 2011
Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL)Anjali S Advani, Sarah Gibson, Elizabeth Douglas, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 16, 2015
Non-t(6;9) and Non-Inv(3) Balanced Chromosomal Rearrangements Are Associated With Poor Survival Outcomes in Myelodysplastic SyndromesJing Ai, Valeria Visconte, Ali Tabarroki, et al.
Pageof 11